Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams(269 views visite) Miralbell R, Cella L, Weber D, Lomax A
Keywords Parole chiave: Intensity Modulation, Meningioma, Orbital Tumors, Protontherapy, Rhabdomyosarcoma, Article, Beam Therapy, Case Report, Human, Lymphoma, Optic Nerve Tumor, Orbit Tumor, Priority Journal, Radiation Dose Distribution, Radiation Injury, Treatment Planning, X Ray, Optic Nerve Neoplasms, Orbital Neoplasms, Radiotherapy, Conformal, Skull Neoplasms, Sphenoid Bone, Tomography, X-Ray Computed,
Affiliations Affiliazioni: Division de Radio-Oncologie, Hôpitaux Universitaires, Genève, Switzerland Strahlenmedizin Abteilung, Paul Scherrer Institut, Villigen, Switzerland
References Riferimenti: Eulau, S.M., Hildebrand, R., Warnke, R., Primary radiotherapy is curative for CS IE orbital MALT lymphoma (1997) Int J Radiat Oncol Biol Phys, 39 (SUPPL. 2), p. 176. , (Abstr.
Wygoda, M.R., Eisbruch, A., Lichter, A.S., Primary orbital and ocular adnexal lymphomas: Excellent outcome with radiotherapy (1999) Proc ASCO, 18, p. 32. , (Abstr.)
Lee, A.G., Woo, S.Y., Miller, N.R., Improvement in visual function in an eye with presumed optic nerve sheath meningioma after treatment with three-dimensional conformal radiation therapy (1996) J Clin Neuro Ophthalmol, 16, pp. 247-251
Kupersmith, M.J., Warren, F.A., Newall, J., Irradiation of meningiomas of the intracranial anterior visual pathway (1987) Ann Neurol, 21, pp. 131-137
Goldsmith, B.J., Wara, W.M., Wilson, C.B., Postoperative irradiation for subtotally resected meningiomas (1994) J Neurosurg, 80, pp. 195-201
Crist, W.M., Garnsey, L., Beltangady, M.S., Prognosis in children with Rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II (1990) J Clin Oncol, 8, pp. 443-452
Benk, V., Rodary, C., Donaldson, S.S., Parameningeal rhabdomyosarcoma: Results of an international workshop (1996) Int J Radiat Oncol Biol Phys, 36, pp. 533-540
Archambeau, J.O., Slater, J.D., Slater, J.M., Role for proton beam irradiation in treatment of pediatric CNS malignancies (1992) Int J Radiat Oncol Biol Phys, 22, pp. 287-294
Miralbell, R., Crowell, C., Suit, H.D., Potential improvement of three dimension treatment planning and protontherapy in the outcome of maxillary sinus cancer (1992) Int J Radiat Oncol Biol Phys, 22, pp. 305-310
Slater, J.M., Slater, J.D., Archambeau, J.O., Carcinoma of the tonsillar region: Potential for use of proton beam therapy (1992) Int J Radiat Oncol Biol Phys, 22, pp. 311-319
Miralbell, R., Lomax, A., Bortfeld, T., Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: Reduction of the supratentorial target volume (1997) Int J Radiat Oncol Biol Phys, 38, pp. 477-484
Lomax, A.J., Bortfeld, T., Goitein, G., A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy (1999) Radiother Oncol, 51, pp. 257-271
Lomax, A., Cozzi, L., Tercier, P.-A., The exchange of radiotherapy data as part of an electronic patient referral system Int J Radiat Oncol Biol Phys, , In press
Scheib, S., Pedroni, E., Dose calculations and optimisation for 3D conformal voxel scanning (1992) Radiat Environ Biophys, 31, pp. 251-256
Bortfeld, T., Buerkelbach, J., Boesecke, R., Three-dimensional solution of the inverse problem in conformation radiotherapy (1992) Advanced Radiation Therapy: Tumor Response Monitoring and Treatment Planning, pp. 503-508. , A. Breit. Berlin: Springer Verlag
Lomax, A., Intensity modulation methods for proton radiotherapy (1999) Phys Med Biol, 44, pp. 185-205
Bortfeld, T., Stein, J., Preiser, K., Clinically relevant intensity modulation optimisation using physical criteria (1997) Proceedings of XII International Conference on the Use of Computers in Radiation (ICCR), pp. 1-4. , In: Leavitt DD, Starkschall G, editors Madison: Medical Physics Publishing
Emami, B., Lyman, J., Brown, A., Tolerance of normal tissue to therapeutic irradiation (1991) Int J Radiat Oncol Biol Phys, 21, pp. 109-122
Lomax, A., Scheib, S., Munkel, G., The comparison of spot scanning proton radiotherapy with conventional photon therapies (1994) XIth International Conference on the Use of Computers in Radiation Therapy, pp. 366-367. , In: Hounsell AR, Wilkinson JM, Williams PC, editors Manchester: North Western Medical Physics Department
Lyman, J.T., Complication probability as assessed from dose-volume histograms (1985) Radiat Res, 104, pp. 513-519
Eng, T.Y., Albright, N.W., Kuwahara, G., Precision radiation therapy for optic nerve sheath meningiomas (1992) Int J Radiat Oncol Biol Phys, 22, pp. 1093-1098
Ron, E., Modan, B., Boice, J.D., Tumors of the brain and nervous system after radiotherapy in childhood (1988) N Engl J Med, 319, pp. 1033-1039
Heyn, R., Haeberlen, V., Newton, W.A., Second malignant neoplasms in chidren treated for rhabdomyosarcoma (1993) J Clin Oncol, 11, pp. 262-270
Scaradavou, A., Heller, G., Sklar, C.A., Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma (1995) Cancer, 76, pp. 1860-1867
Miralbell, R., Linggood, R.M., De La Monte, S., The role of radiotherapy in the treatment of subtotally resected benign meningiomas (1992) J Neuro Oncol, 13, pp. 157-164
Regine, W.F., Fontanesi, J., Kumar, P., Local tumor control in rhabdomyosarcoma following low-dose irradiation: Comparison of group II and selected group III patients (1995) Int J Radiat Oncol Biol Phys, 31, pp. 485-491
Raney, R.B., Wharam, M., Glicksman, A.S., Late sequelae in survivors of localized non-orbital rhabdomyosarcoma of the head and neck: A final report from IRSG studies II and III, 1978-1987 (1998) Med Pediatr Oncol, 31, p. 233. , (Abstr.)
Parsons, J.T., Bova, F.J., Fitzgerald, C.R., Severe dry-eye syndrome following external beam irradiation (1994) Int J Radiat Oncol Biol Phys, 30, pp. 775-780
Takeda, A., Shigematsu, N., Suzuki, S., Late retinal complications of radaition rherapy for nasal and paranasal malignanicies: Relationship between irradiated-dose area and severity (1999) Int J Radiat Oncol Biol Phys, 44, pp. 599-605
Burman, C., Kutcher, G.J., Emami, B., Fitting of normal tissue tolerance data to an analytic function (1991) Int J Radiat Oncol Biol Phys, 21, pp. 123-135
Eulau, S. M., Hildebrand, R., Warnke, R., Primary radiotherapy is curative for CS IE orbital MALT lymphoma (1997) Int J Radiat Oncol Biol Phys, 39 (SUPPL. 2), p. 176. , (Abstr.
Wygoda, M. R., Eisbruch, A., Lichter, A. S., Primary orbital and ocular adnexal lymphomas: Excellent outcome with radiotherapy (1999) Proc ASCO, 18, p. 32. , (Abstr.)
Smith, J. L., Vuksanovic, M. M., Yates, B. M., Radiation therapy for primary optic nerve meningiomas (1981) J Clin Neuro Ophthalmol, 1, pp. 85-89
Lee, A. G., Woo, S. Y., Miller, N. R., Improvement in visual function in an eye with presumed optic nerve sheath meningioma after treatment with three-dimensional conformal radiation therapy (1996) J Clin Neuro Ophthalmol, 16, pp. 247-251
Kupersmith, M. J., Warren, F. A., Newall, J., Irradiation of meningiomas of the intracranial anterior visual pathway (1987) Ann Neurol, 21, pp. 131-137
Goldsmith, B. J., Wara, W. M., Wilson, C. B., Postoperative irradiation for subtotally resected meningiomas (1994) J Neurosurg, 80, pp. 195-201
Crist, W. M., Garnsey, L., Beltangady, M. S., Prognosis in children with Rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II (1990) J Clin Oncol, 8, pp. 443-452
Archambeau, J. O., Slater, J. D., Slater, J. M., Role for proton beam irradiation in treatment of pediatric CNS malignancies (1992) Int J Radiat Oncol Biol Phys, 22, pp. 287-294
Slater, J. M., Slater, J. D., Archambeau, J. O., Carcinoma of the tonsillar region: Potential for use of proton beam therapy (1992) Int J Radiat Oncol Biol Phys, 22, pp. 311-319
Lomax, A. J., Bortfeld, T., Goitein, G., A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy (1999) Radiother Oncol, 51, pp. 257-271
Lyman, J. T., Complication probability as assessed from dose-volume histograms (1985) Radiat Res, 104, pp. 513-519
Eng, T. Y., Albright, N. W., Kuwahara, G., Precision radiation therapy for optic nerve sheath meningiomas (1992) Int J Radiat Oncol Biol Phys, 22, pp. 1093-1098
Regine, W. F., Fontanesi, J., Kumar, P., Local tumor control in rhabdomyosarcoma following low-dose irradiation: Comparison of group II and selected group III patients (1995) Int J Radiat Oncol Biol Phys, 31, pp. 485-491
Raney, R. B., Wharam, M., Glicksman, A. S., Late sequelae in survivors of localized non-orbital rhabdomyosarcoma of the head and neck: A final report from IRSG studies II and III, 1978-1987 (1998) Med Pediatr Oncol, 31, p. 233. , (Abstr.)
Parsons, J. T., Bova, F. J., Fitzgerald, C. R., Severe dry-eye syndrome following external beam irradiation (1994) Int J Radiat Oncol Biol Phys, 30, pp. 775-780
Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams
Purpose: This study presents a dosimetric optimization effort aiming to compare intensity-modulated (IM) X-rays and IM protons in 4 different orbital and paraorbital tumors. These are most challenging targets for standard radiotherapy due to their close relationship with the eyes and related structures.Methods and Materials: A primary orbital lymphoma, an optic nerve meningioma, a sphenoidal ridge meningioma protruding into the orbit, and a pediatric parameningeal paraorbital rhabdomyosarcoma were selected for the purpose of this study. Planning target volumes (PTVs) and organs at risk (OAR) were defined in each patient CT data set for each tumor site. IM X-ray and IM proton three-dimensional treatment plans were implemented. The following total tumor doses were prescribed: 30 Gy for the orbital lymphoma, 54 Gy for both meningiomas, and 50.4 Gy for the rhabdomyosarcoma case. Dose-volume histograms (DVHs) were obtained for all targets and OAR with both treatment techniques. DVHs were used to predict normal tissue complication probabilities (NTCPs) for the OAR in the vicinity of the tumor.Results: The PTV coverage was optimal and equally homogeneous with both IM X-rays and IM proton plans in the 4 tumor sites. DVHs for most OAR were better with IM proton beams especially in the low- to mid-dose range region. The integral nontarget dose was lower with IM protons in every case (factor ranging from 1.5 to 1.9). However, predicted NTCPs (for severe late effects) were equally low for both treatment techniques in every tumor site.Conclusion: Although IM proton plans optimally decreased the dose to the OAR in all tumor sites, both optimized X-ray and proton beams equally succeeded to reduce severe-toxicity prediction risks to less than 5% while optimally treating the PTV. Copyright (C) 2000 Elsevier Science Inc.
Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(203 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(282 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(422 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(227 visite) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 DettagliEsporta in BibTeXEsporta in EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(406 visite) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 DettagliEsporta in BibTeXEsporta in EndNote